The EU Commission publishes its 5th patent monitoring report

DG Competition of the European Commission just published its 5th patent monitoring report. It covers patent settlements entered into in 2013. Each year, the Commission claims that the report shows a “steady increase” of patent settlements in general, which supposedly would prove that the Commission’s threat of vigorous enforcement against so-called reverse patent settlements does not prevent pharmaceutical companies from settling patent disputes. The Commission also claims a steady decrease of “problematic settlements”, namely those including a value transfer and a limitation of the generic’s ability to enter the market immediately with its own product. We published a client alert last year warning that the Commission’s conclusions were unsound. The criticism equally applies to this year’s

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • General Court of the European Union (Luxembourg)
  • White & Case (Brussels)
  • White & Case (Brussels)
  • White & Case (Brussels)

Citation

Ian Forrester, James Killick, Mark D. Powell, Jérémie Jourdan, The EU Commission publishes its 5th patent monitoring report, 5 décembre 2014, Bulletin e-Competitions December 2014, Art. N° 73803

Visites 278

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues